Among MSS nonresponders, 86.6% (n = 246) showed insufficient tumor-infiltrating CD8+ T cells and 2.8% (n = 8) showed sufficient tumor-infiltrating CD8+ T cells; however, those CD8+ T cells display patterns of terminally exhausted CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.